Safety, tolerability, and immunogenicity of the chimpanzee adenovirus type 3-vectored Marburg virus (cAd3-Marburg) vaccine in healthy adults in the USA: a first-in-human, phase 1, open-label, dose-escalation trial.
第一作者:
Melinda J,Hamer
第一单位:
Walter Reed Army Institute of Research, Silver Spring, MD, USA; Department of Emergency Medicine, George Washington University School of Medicine and Health Sciences, Washington, DC, USA.
作者:
医学主题词
动物(Animals);成年人(Adult);人类(Humans);黑猩猩属(Pan troglodytes);马尔堡病毒属(Marburgvirus);抗体, 病毒(Antibodies, Viral);腺病毒, 猴(Adenoviruses, Simian);疫苗, 合成(Vaccines, Synthetic);腺病毒科(Adenoviridae);糖蛋白类(Glycoproteins);双盲法(Double-Blind Method)
DOI
10.1016/S0140-6736(22)02400-X
PMID
36709074
发布时间
2025-05-30
基金项目
Z99 AI999999/ImNIH/Intramural NIH HHS/United States
- 浏览3
Lancet (London, England)
294-302页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



